Ciprofloxacin Tablet
Product Images NDC 71335-2502

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 71335-2502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C17h18fn3o3•hcl•h2o (Image 01)

C17h18fn3o3•hcl•h2o (Image 01)
Chemical structure of ciprofloxacin hydrochloride monohydrate, showing the molecular framework including piperazine and fluorine substituents.*
FDA Label Image

C17h18fn3o3 (Image 02)

C17h18fn3o3 (Image 02)
Chemical structure of ciprofloxacin, a fluoroquinolone antibiotic, showing its characteristic bicyclic quinolone core with a fluorine atom and a piperazine moiety.*
FDA Label Image

Label (Lbl713352502)

Label (Lbl713352502)
The image shows a label for Ciprofloxacin Tablets, USP 250 mg, oral tablets. The label states each tablet contains Ciprofloxacin Hydrochloride equivalent to 250 mg Ciprofloxacin. It indicates packaging of 20 tablets, repackaged by Bryant Ranch Prepack, Inc. and manufactured by Yiling Pharmaceutical Ltd. The label includes storage instructions and a barcode with NDC 71335-2502-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.